Influence of size and polarity of residue 31 in porcine pancreatic phospholipase A2 on catalytic properties by Kuipers, Oscar P. et al.
  
 University of Groningen
Influence of size and polarity of residue 31 in porcine pancreatic phospholipase A2 on
catalytic properties
Kuipers, Oscar P.; Kerver, Jana; Meersbergen, Joop van; Vis, Roel; Dijkman, Ruud; Verheij,
Hubertus M.; Haas, Gerard H. de
Published in:
%22Protein Engineering%2C Design and Selection%22
DOI:
10.1093/protein/3.7.599
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1990
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kuipers, O. P., Kerver, J., Meersbergen, J. V., Vis, R., Dijkman, R., Verheij, H. M., & Haas, G. H. D. (1990).
Influence of size and polarity of residue 31 in porcine pancreatic phospholipase A2 on catalytic properties.
%22Protein Engineering%2C Design and Selection%22, 3(7). https://doi.org/10.1093/protein/3.7.599
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Protein Engineering vol.3 no.7 pp.599-603, 1990
Influence of size and polarity of residue 31 in porcine pancreatic
phospholipase A2 on catalytic properties
Oscar P.Kuipers, Jana Kerver, Joop van Meersbergen,
Roel Vis, Ruud Dijkman, Hubertus M.Verheij1 and
Gerard H.de Haas
Department of Biochemistry, University of Utrecht, Center for
Biomembranes and Lipid Enzymology, PO Box 80.054, NL-3508 TB
Utrecht, The Netherlands
ITo whom correspondence should be addressed
Residue 31 of porcine pancreatic phospholipase A2 (PLA2)
is located at the entrance to the active site. To study the role
of residue 31 in PLA2, six mutant enzymes were produced
by site-directed mutagenesis, replacing Leu by either Trp,
Arg, Ala, Thr, Ser or Gly. Direct binding studies indicated
a three to six times greater affinity of the Trp31 PLA2 for
both monomeric and micellar substrate analogs, relative to
the wild-type enzyme. The other five mutants possess an
unchanged affinity for monomers of the product analog
n-decylphosphocholine and for micelles of the diacyl substrate
analog rac-l,2-dioctanoylamino-dideoxy-glycero-3-phospho-
choline. The affinities for micelles of the monoacyl product
analog n-hexadecylphosphocholine were decreased 9 - 20
times for these five mutants. Kinetic studies with monomeric
substrates showed that the mutants have Vmax values which
range between 15 and 70% relative to the wild-type enzyme.
The Vmax values for micelles of the zwitterionic substrate
1,2-dioctanoyl-sn-glycero-3-phosphocholine were lowered
3 - 50 times. The Km values for the monomeric substrate and
the Km values for the micellar substrate were hardly affected
in the case of five of the six mutants, but were considerably
decreased when Trp was present at position 31. The results
of these investigations point to a versatile role for the residue
at position 31: involvement in the binding and orientating of
monomeric substrate (analogs), involvement in the binding
of the enzyme to micellar substrate analogs and possibly
involvement in shielding the active site from excess water.
Key words: phospholipase A2/site-directed mutagenesis/lipolysis
Introduction
The lipolytic enzyme phospholipase A2 (EC 3.1.1.4) specifically
hydrolyzes the 2-acyl linkage of phosphoglycerides in a calcium-
dependent reaction (Waite, 1987). Phospholipases occur both
extracellularly and intracellularly. The extracellular enzymes are
found abundantly in mammalian pancreas and in snake or bee
venoms serving a digestive function. The intracellular
phospholipases, which are thought to play an important role in
inflammation processes, are found in low concentrations in nearly
every mammalian cell (Waite, 1987). A high degree of sequence
homology is found in phospholipases of over 50 species (van den
Bergh et al., 1989). All these PLA2s have a molecular mass
between 13.5 and 14 kd and contain six or seven disulfide
bridges. The three-dimensional (3-D) structures of several
PLA2s from bovine and porcine pancreas and from Crotalus
atrox venom have been determined by X-ray crystallography and
demonstrate that these enzymes are structurally similar (Dijkstra
et al., 1981a, 1983; Renetseder et al., 1985; Brunie et al., 1985).
An intriguing property of lipolytic enzymes is their ability to
hydrolyze aggregated substrates, e.g. micelles, vesicles and
liposomes, at much higher velocities than monomeric substrate
molecules. The hydrolysis of aggregated substrates first requires
the binding of the enzyme to the lipid -water interface. After
binding of the enzyme to the lipid aggregate, one single substrate
molecule is thought to diffuse into the active site, where it is
hydrolyzed. A mechanism for catalysis has been proposed
previously (Verheij et al., 1980).
Chemical modification studies and semisynthesis of
phospholipases from various sources have indicated Leu2, Trp3,
Arg6, Leu19, Met20, Leu31 and Tyr69 in the porcine enzyme
to be involved in the binding of the enzyme to aggregated
phospholipids (Volwerk and de Haas, 1982). Inspection of the
three-dimensional structures of bovine and porcine pancreatic
PLA2s shows that these residues are present as a cluster of
mainly hydrophobic and positively charged residues, located at
one face of the enzyme, and surrounding the active site (Dijkstra
et al., 1981b). The three-dimensional structures of the pancreatic
enzymes show that Leu31 and Tyr69 both lie at the entrance to
the active site (Dijkstra et al., 1981b). The position of these
residues with respect to the active site is illustrated in Figure 1.
Recently, Tyr69 has been the subject of a site-directed
mutagenesis study, showing the involvement of this residue in
the binding of the phosphate moiety of phospholipids (Kuipers
et al., 1989a). A comparison of the sequences of phospholipases
Fig. 1. Cross section of the active site of phospholipase A2. Section through
the middle of the enzyme showing the essential residues for catalysis
(His48, Asp49 and the Cα of Asp99). The van der Waals surfaces of Leu31
and Tyr69, at the entrance of the active site, are shaded. Substrate
molecules are supposed to approach the cleft from the direction of the
arrow.
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1. Y G C Y C G L G G S G T P V D E L D R C C E T H D N C Y
2. * * * * * * R * * * * * * * * D * * * * * Q I * * * * *
3. * * * * * * A * * * * * * * * * * * * * * K I * * * * *
4. * * * * * * W * * K * K * I * A T * * * * F V * * C * *
5. * * * * * * S * * R * K * K * A T * * * * F V * * C * *
6. * * * * * * G * * Q * K * K * G T * * * * F V * * C * *
Fig. 2. Comparison of the sequences of porcine pancreatic and five snake venom phospholipases A2 in the region of residue 31. 1, Porcine pancreatic; 2,
Naja melanoleuca fraction DE III; 3, Laticauda semifasciata fraction I; 4, Bitis gabonica; references to the publication of these (and many other) sequences
have been published by Dufton et al. (1983). 5, Agkistrodon halys blomhofii basic (Forst et al., 1986); 6, Agkistrodon halys Pallas (Kondo et al., 1989).
Sequence numbering is according to Renetseder et al. (1985).
from different species shows that in mammalian pancreatic
phospholipases a Leu is invariably present at position 31, whereas
in >85 % of the known snake venom PLA2 sequences Trp, Arg
or Ala is found (van den Bergh et at., 1989). A comparison of
the porcine pancreatic sequence with those of five representative
snake venom PLA2s in the region of residue 31 is given in
Figure 2. Chemical modification of Trp31 in Bitis gabonica by
N-bromosuccinimide greatly diminished enzymatic activity
(Viljoen et at., 1976). The inability of the modified enzyme to
bind to the aggregated substrate was given as an explanation for
this decrease in activity.
To study the role of residue 31 in more detail, six amino acid
substitutions for Leu at position 31 of porcine pancreatic
phospholipase A2 were introduced by site-directed mutagenesis.
A degenerated oligonucleotide, yielding simultaneously the
mutations Trp, Arg, Ala, Thr, Ser and Gly at position 31, was
used for this purpose. The effects of the substitutions on the
catalytic activities of the mutant enzymes on both monomeric
and micellar substrates were determined. The binding properties
of the mutants to monomeric and micellar substrate analogs were
investigated with fluorescence spectroscopy.
Materials and methods
Construction and purification of mutant phospholipases
Escherichia coli K-12 strain PC 2494 [Δ(lac-pro), sup E, thi/F'
tra D36, pro A +B+, lac Iq, lacZ ΔM15; Phabagen collection,
Utrecht] was used for plasmid constructions and as a host for
M13-derived vectors. HB 2154 [ara, Δ (lac-pro), thi/F' pro
A +B+, lac Iq, lacZ ΔM25, mut L::Tn10] (Carter et at., 1985)
was used as recipient strain in the mutagenesis experiments.
Substitutions in the proPLA2-cDNA (de Geus et at., 1987) were
introduced by the gapped duplex procedure, using amber selection
(Kramer et al., 1984). The degenerated mutagenic oligo-
nucleotide 5'-C.TGA.TCC.ACC.C(G or C)(A or T or C).GCc.
ACA.GTA.GC-3' was used for site-directed mutagenesis at
position 31. It was synthesized on a Biosearch 6800 DNA
synthesizer. The sites of mutation in the sequence of the
oligonucleotide are underlined. The resulting mutant
proPLA2-cDNA was sequenced by the dideoxy-chain-
termination method after plaque purifying (Sanger et aI., 1977)
and a BamHI - BstXI fragment of each mutant proPLA2-cDNA
was cloned into the expression vector described by Kuipers et al.
(1989a). After transformation and expression in E. coli K-12 strain
MC4100 (Casadaban, 1976), containing plasmid pCI857, the
mutant phospholipases were obtained by tryptic cleavage of
reoxidized fusion protein (de Geus et al., 1987) and purified by
CM-cellulose chromatography at pH 5 and 6. Final purification
to homogeneity was achieved on DEAE-cellulose at pH 8.0.
Protein concentrations were determined from the absorbance at
280 nm, using an E1cm1%= 13.0 for the wild-type and five
mutant enzymes, and an E1cm1%= 18.0 for the Trp31 mutant.
Stock solutions of PLA2 routinely contained at least
0.25 mg/ml.
Phospholipids
The 1,2-diacyl-sn-glycero-3-phosphocholines used in this study
were obtained after reacylation of sn-glycero-3-phosphocholine.
Rac-1,2-dihexanoyldithio-glycero-3-phosphocholine
(diC6dithioPC) was obtained as described by Volwerk et al.
(1979). N-Decylphosphocholine (C10PN) and n-
hexadecylphosphocholine (C16PN) were prepared as described
by van Dam-Mieras et al. (1975). The diacyl phospholipid analog
rac-1 ,2-dioctanoy lamino-dideoxy-glycero-3-phosphocholine
(diC8diamidoPC) was prepared in analogy to the methods
described by Bonsen et al. (1972) and by Dijkman et al. (1990).
Phospholipase assays
Quantitative measurements with 1,2-dioctanoyl-sn-glycero-
3-phosphocholine (diC8PC) as a substrate were carried out with
a titrimetric assay at pH 8 in the presence of 1 mM borate,
25 mM CaCl2 and 100 mM NaCl at 25°C. The burette of the
Radiometer ABU was filled with 10 mM sodium hydroxide.
Activities on monomeric diC6dithioPC were determined at pH
8 in the presence of 200 mM Tris, 100 mM NaCl and 100 mM
CaCI2, as described previously (Volwerk et al., 1979).
Direct binding of PLA2 to monomers and micelles
The affinity of phospholipase A2 for monomers and micelles
was determined by following the increase of tyrosine and
tryptophan fluorescence upon addition of increasing concen-
trations of the non-hydrolysable substrate analogs C10PN (CMC
10 mM) or diC8diamidoPC (CMC 1.7 mM) for monomer
binding, and C16PN (CMC 10 µM) or diC8diamidoPC for
micelle binding. Fluorescence studies were performed in a buffer
containing 100 mM NaAc, 50 mM CaCl2 and 100 mM NaCl
at pH 6.0. Excitation wavelength was at 280 nm. From saturation
curves, obtained with lipid monomers, a Kd value can be
derived directly. The data concerning micelle binding were
analyzed in terms of the binding of the enzyme to a theoretical
lipid particle consisting of N monomers with a dissociation
600
Mutations of Leu31 of phospholipase A2
Table I. Binding of wild-type and six mutant PLA2s to the monomeric substrate analogs CIOPN and diC8diamidoPC and kinetic constants measured with the
monomeric substrate diC6dithioPC
Enzyme CIOPN diC8diamidoPC diC6dithioPC
Kd (mM) Kd (mM) Km (mM) kca'(s -I) kcat/Km (s-I/M)
Wild-type (Leu31) 3.3 0.8 0.8 0.71 900
Trp31 0.6 0.3 0.2 0.52 2450
Arg31 3.0 0.9 0.7 0.26 380
Ala31 3.0 1.0 0.7 0.12 160
Thr31 3.1 1.0 1.0 0.11 110
Ser31 2.9 0.8 1.0 0.16 160
Gly31 4.1 0.8 1.0 0.07 70
CIOPN stands for n-decylphosphocholine, diC8diamidoPC stands for rae-I,2-dioctanoylamino-dideoxy-glycero-3-phosphocholine and diC6dithioPC stands for
rae 1,2-dihexanoyldithio-sn-glycero-3-phosphocholine. Standard errors were ~10% of each given value. For details see Materials and methods.
Table II. Binding of wild-type and six mutant PLA2s to the micellar substrate analogs CI6PN and diC8diamidoPC and enzymatic activities on two micellar
substrates
Enzyme CI6PN diC8diamidoPC diC8PC
N·Kd (µM) N·Kd (mM) Km (mM) Vmax
(µmol/min/mg)
Wild-type (Leu31) 70 3.9 3.7 2000
Trp31 17 0.8 0.5 600
Arg31 640 3.5 3.7 180
Ala31 570 3.2 3.9 60
Thr31 > 1200 3.7 3.3 50
Ser31 > 1200 4.3 3.7 50
Gly31 > 1200 4.6 5.9 40
The substrate concentration of 1,2-dioctanoyl-sn-glycero-3-phosphocholine (diC8PC) was varied between 0.5 and 10 mM. CI6PN stands for n-hexadecyl-
phosphocholine and diC8diamidoPC stands for rae-I,2-dioctanoylamino-dideoxy-glycero-3-phosphocholine. Accuracy was ~10% for each given value. For
details see Materials and methods.
constant Kd. As has been discussed extensively by de Araujo
et al. (1979), the N·Kd value is the experimental concentration
at which 50% of the enzyme is saturated with micelles.
Results
Binding properties of wild-type and mutant PLA2s to monomeric
substrate analogs and enzymatic activities on monomeric
substrates
The binding properties of wild-type and six PLA2s mutated at
residue 31 were determined by fluorescence spectroscopy, using
C 10PN and diC8diamidoPC as substrate analogs at concentrations
below the critical micelle concentration (CMC). Kinetic studies
with these enzymes were performed with the monomeric substrate
diC6dithioPC. The results of these studies are summarized in
Table I. The dissociation constants for monomeric C 10PN and
diC8diamidoPC did not change significantly for most mutant
enzymes, with the exception of the smallest residue at position
31, i.e Gly, which caused a small loss of affinity for monomeric
C10PN. This fact might be explained by a slightly changed loop
structure, in view of the general notion that a Gly residue can
locally increase the flexibility of a peptide chain. A significant
increase in affinity was observed only when a Trp was present.
The Km values determined with the monomeric substrate
diC6dithioPC show the same tendency as the Kd values obtained
with the direct binding studies. The fact, however, that most
mutations at position 31 in PLA2 hardly affected the dissociation
constants for C10PN and diC8diamidoPC monomers, nor the
Km value for diC6dithioPC monomers, indicates that the side
chain of residue 31 is not directly involved in the binding of the
monomeric substrate molecule. Apparently, only the Trp side
chain is bulky and hydrophobic enough to give a substantial
contribution to the binding of monomeric phospholipids via
hydrophobic interaction with one or with both of the acyl chains
of the substrate analog molecule.
Although the kinetic studies show a minor effect of the
mutations on the affinity for monomeric substrates except in the
case of Trp, there is considerable effect on the kcat value. The
effects on kcat could be related to the size and/or polarity of the
residue at position 31. An increased polarity (Arg) or a decreased
size (Ala, Thr, Ser, Gly) cause a decrease in kcat. It is, however,
hard to predict the exact effect of size and polarity of residue
31 on kcat' as long as a detailed understanding of substrate and
transition state binding is not available. The mutant enzymes,
except the Trp31 mutant, all have a significantly lower specificity
constant (kcat/ Km) than the wild-type enzyme, mainly due to the
reduced kcat values.
Binding properties of wild-type and mutant PLA2s to micellar
substrate analogs and enzymatic activities on micellar substrates
The binding properties of wild-type and six mutant enzymes to
micelles were determined by fluorescence spectroscopy, with the
monoalkyl substrate analog C16PN and the diacyl substrate
analog diC8diamidoPC (Table II). Because the former substrate
analog contains only one alkyl chain, whereas the latter one
contains two acyl chains, the mode of binding of these molecules
by PLA2 could be different. This was indeed observed, since
from the data in Table II it is clear that the mutants have a
decreased affinity for C 16PN micelles, but retain their affinity
for micelles of diC8diamidoPC. Only the Trp31 mutant displayed
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an increased affinity for micelles of both C16PN and
diC8diamidoPC.
Kinetic studies with micellar zwitterionic diC8PC were
performed titrimetrically using a pH stat (Table II). With micellar
substrates saturation curves are obtained which can be interpreted
as Michaelis - Menten type of kinetics yielding Vmax and Km
values. However, as has been discussed extensively by Verger
and de Haas (1976), the kinetic constants are apparent values.
This is caused by the fact that the enzyme binds to its substrate
in a two-step process. First, interaction occurs between the
enzyme and the micelle, and subsequently a single substrate
molecule is bound in the active site where hydrolysis occurs. By
adding more micelles all the enzyme can become bound to the
interface, but the concentration of monomers in the interface,
and consequently the active site occupancy, remains constant.
The kinetic analyses with this substrate at concentrations well
above the CMC, revealed that for all mutants the Km value had
not changed greatly, except in the case of the Trp31 mutant. A
similar tendency can also be observed when looking at the
experimental values at which half of the enzyme is saturated with
lipids (N·Kd values) as they are obtained in the direct binding
studies with the substrate analog diC8diamidoPC. In contrast to
the minor effects of the mutations on the Km values, the
mutations have a large effect on the observed Vmax values. In
the case of the Trp31 mutant this effect is only moderate, but
the introduction of more polar and/or smaller amino acid side
chains gives rise to 10-50 times lower Vmax values.
Discussion
When the affinity of (mutant) phospholipases for monomeric
substrate analogs was determined, no divergence in the relative
affinities of these enzymes for substrate analogs containing either
one alkyl or two acyl chains was observed. Thus, both types of
analog seem to be appropriate molecules for studying the binding
of PLA2 species to phospholipids below their CMCs. With
micelles of these substrate analogs clear differences were
observed. Direct binding studies with the micellar substrate analog
C 16PN indeed show the great importance of a large hydrophobic
residue at position 31. The bulky Trp residue improves the affinity
of the enzyme for these micelles 4-fold, whereas the other five
mutations cause a great reduction in affinity for C16PN micelles.
However, with diC8diamidoPC as a micellar substrate analog,
no such loss in affinity was observed with these five mutants.
This interesting difference in affinity of these five mutants for
the two micellar substrate analogs could be caused by several
features of these compounds. The first difference is that C16PN
has only one alkyl chain, whereas diC8diamidoPC contains two
acyl chains resulting in a different mode of binding of the enzyme
to these interfaces. For example, it could be that one acyl chain
of diC8diamidoPC interacts with the enzyme, whereas the se-
cond acyl chain could serve as an 'anchor' when the enzyme is
bound to these micelles. This effect could cancel out the effects
of the mutations. The second difference between these two
substrate analogs could be the way in which they are packed in
a micelle. The CMC of C16PN is ~200 times lower than the
CMC of diC8diamidoPC. It is generally accepted that micelles
of compounds with a low CMC are more densely packed than
micelles of compounds with a higher CMC. The interaction of
pancreatic phospholipases is very sensitive to changes in packing
density of aggregated phospholipids in monomolecular surface
films and in bilayer systems (Verger and de Haas, 1976) and
the interaction with micelles might be regulated in the same way.
If indeed a large hydrophobic residue on position 31 is important
for the interaction with densely packed interfaces, one can
understand that the mutants with smaller side chains have reduced
binding to the more densely packed micelles, whereas binding
to more loosely packed micelles remains unchanged. Our results
show that the affinity of (mutant) enzyme for diacyl phospholipid
micelles can be measured by direct binding studies with diacyl
substrate analogs but that results obtained with
monoalkylphosphocholines should be interpreted with care. The
Km values for the six mutants with diC8PC as a substrate agree
quite well with the N· Kd values derived from the direct binding
studies with the non-hydrolyzable substrate analog
diC8diamidoPC.
All mutants have reduced hydrolysis rates and the question
arises what causes this effect. Several factors could contribute
to this reduced catalytic efficiency. One of these factors could
be that the three-dimensional structures of the mutants have been
changed. We assume that the conformations of the mutants have
not been altered significantly, at least not in the region of the
active site, for the following reasons. The three-dimensional
structures of bovine and porcine PLA2 (Leu31) and of C.atrox
PLA2 (Trp31) are highly similar (Renetseder et al., 1985).
Moreover, the high variability in natural phospholipases for the
residue at position 31, taken together with its location at the
surface of the enzyme, does not suggest a structural role for this
residue. However, in the case of Gly31, a small conformational
change cannot be excluded a priori, in view of the known
deviations in φ and ψ torsion angles, which could influence the
local conformation of the peptide chain. Indeed, this mutant
displays the lowest activities and the lowest substrate affinities
of all tested mutants. In 1985 van Scharrenburg et al. showed
with laser-induced Eu3+ luminescence studies that, upon binding
of PLA2 to monomeric substrate analogs, one water molecule
was excluded from the active site. In the presence of micellar
concentrations of this analog four water molecules were excluded
and the authors proposed that this increased dehydration could
be an important reason for the enhanced activity of PLA2 at
lipid -water interfaces. Our kinetic studies with the monomeric
substrate diC6dithioPC showed that kcat values were lowered by
the mutations at 31 . We assume that the introduction of a smaller
and/or more polar residue than Leu at position 31 causes a less
effective shielding of the active site by the residue at position
31, resulting in a less efficient dehydration process of the active
site. With monomeric substrate the reduction in kcat values is
only moderate, whereas the reduction in hydrolysis rates is
~10-fold stronger with micellar substrates. This suggests that
dehydration of the active site is more critically dependent upon
the side chain at 31, when the enzyme is bound to interfaces rather
than acting in water. Considering the mutations at 31 that affect
activity, both the size and polarity of the amino acid side chains
of these mutants could be important. The fact that the charged,
but relatively large, arginine residue displays the highest catalytic
rates of all polar residues at position 31 suggests that size could
be more important than charge. To obtain a more complete insight
in the role of size and polarity on catalytic rates and substrate
binding it would be interesting to investigate the catalytic
properties of mutants carrying any of the other 13 possible
residues at position 31. We have restricted ourselves, however,
to those residues that are encountered also in naturally occurring
PLA2s, to ensure a high probability of correctly folded and
active mutant enzymes. In addition to the above explanation for
the decrease in activity of all the mutants, several other factors
may playa role. First, it is conceivable that the size of the side
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chain at 31, which is close to the entrance of the active site (Figure
1), influences the orientation of the substrate molecule relative
to the active site residues. Second, it could also be that Leu31
gives a more favorable interaction with the transition state than
the other six residues at position 31, resulting in lower kcat
values for the mutants. Third, although the dissociation constants
(N·Kd values) are known, the association and dissociation rate
constants which determine this N·Kd value are not known.
Therefore, it is possible that the lifetime of the enzyme-micelle
complex is different for all mutants. Because the complex contains
a large number of substrate molecules per enzyme molecule and
because the turnover numbers are low, variations in the life time
of the complex may very well influence Vmax values.
In 1976, Viljoen et al. found a large decrease in enzymatic
activity of a PLA2 from B.gabonica venom in which the Trp at
position 31 was modified by N-bromosuccinimide. Because the
enzyme was protected against this inactivation by micellar
concentrations of substrate analogs these authors suggested that
Trp31 in this PLA2 was involved in substrate binding. Thus,
inability of binding of the modified protein to substrate micelles
was held responsible for the low catalytic rates of this enzyme.
Our results show that the introduction of more polar residues
at 31 reduces Vmax rather than substrate binding. Because the
oxidation of Trp31 in the venom PLA2 creates a more polar side
chain, the loss in activity after this chemical modification might
very well be explained as a Vmax effect.
In general, snake venom PLA2s, in which a Trp, Arg or Ala
residue is frequently encountered at position 31, are very active
on short chain lecithins. The enzymes from Crotalus adamateus
and from Naja melanoleuca venom, which contain a Trp and
an Arg residue at 31 respectively, are 10 - 20 times more active
on diC8PC than porcine pancreatic PLA2 (Wells, 1972; van
Eijk et at., 1983). Because introduction of either Trp or Arg in
porcine pancreatic PLA2 reduces rather than improves
enzymatic activity, the enhanced activity of the venom PLA2s
cannot be explained by the character of the residues at 31 only.
Since the homology of pancreatic PLA2s with the sequences of
snake venom PLA2s is ranging between 30 and 60% (Waite,
1987), changes in other parts of the sequence probably are
responsible for the difference in activities. One such change is
the surface loop between residues 62 and 66 which is present
in pancreatic phospholipases but lacking in venom
phospholipases. Indeed, removal of this loop from porcine
pancreatic PLA2 increases enzymatic activity on short chain
lecithins considerably (Kuipers et at., 1989b).
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